Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:59:163-180.
doi: 10.1007/978-3-030-67696-4_8.

Impact of Calreticulin and Its Mutants on Endoplasmic Reticulum Function in Health and Disease

Najla Arshad  1 , Peter Cresswell  2   3
Affiliations

Impact of Calreticulin and Its Mutants on Endoplasmic Reticulum Function in Health and Disease

Najla Arshad et al. Prog Mol Subcell Biol. 2021.

Abstract

The endoplasmic reticulum (ER) performs key cellular functions including protein synthesis, lipid metabolism and signaling. While these functions are spatially isolated in structurally distinct regions of the ER, there is cross-talk between the pathways. One vital player that is involved in ER function is the ER-resident protein calreticulin (CALR). It is a calcium ion-dependent lectin chaperone that primarily assists in glycoprotein synthesis in the ER as part of the protein quality control machinery. CALR also buffers calcium ion release and mediates other glycan-independent protein interactions. Mutations in CALR have been reported in a subset of chronic blood tumors called myeloproliferative neoplasms. The mutations consist of insertions or deletions in the CALR gene that all cause a + 1 bp shift in the reading frame and lead to a dramatic alteration of the amino acid sequence of the C-terminal domain of CALR. This alters CALR function and affects cell homeostasis. This chapter will discuss how CALR and mutant CALR affect ER health and disease.

Keywords: Calcium signaling; Calreticulin; Endoplasmic reticulum; Lipid biosynthesis; Myeloproliferative neoplasms; Protein folding.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Molecular biology of the cell. Garland Science, New York
    1. Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei H, Morishita S, Mizukami Y, Kan S, Shirane S, Edahiro Y, Sunami Y, Ohsaka A, Komatsu N (2016) Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood 127(10):1307–1316. https://doi.org/10.1182/blood-2015-09-671172 - DOI - PubMed
    1. Araki M, Yang Y, Imai M, Mizukami Y, Kihara Y, Sunami Y, Masubuchi N, Edahiro Y, Hironaka Y, Osaga S, Ohsaka A, Komatsu N (2019) Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation. Leukemia 33(1):122–131. https://doi.org/10.1038/s41375-018-0181-2 - DOI - PubMed
    1. Arshad N, Cresswell P (2018) Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I. J Biol Chem 293(25):9555–9569. https://doi.org/10.1074/jbc.RA118.002836 - DOI - PubMed - PMC
    1. Bajor A, Tischer S, Figueiredo C, Wittmann M, Immenschuh S, Blasczyk R, Eiz-Vesper B (2011) Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy. Clin Exp Immunol 165(2):220–234. https://doi.org/10.1111/j.1365-2249.2011.04423.x - DOI - PubMed - PMC

LinkOut - more resources